SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001538210-22-000024
Filing Date
2022-08-15
Accepted
2022-08-15 17:06:09
Documents
74
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nexi-20220630.htm   iXBRL 10-Q 1241333
2 EX-10.2 exhibit102-firstamendmentt.htm EX-10.2 8352
3 EX-31.1 nexi-20220630xexx311.htm EX-31.1 10237
4 EX-31.2 nexi-20220630xexx312.htm EX-31.2 10430
5 EX-32.1 nexi-20220630xexx321.htm EX-32.1 4100
6 EX-32.2 nexi-20220630xexx322.htm EX-32.2 4293
  Complete submission text file 0001538210-22-000024.txt   5909262

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nexi-20220630.xsd EX-101.SCH 46220
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nexi-20220630_cal.xml EX-101.CAL 55936
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nexi-20220630_def.xml EX-101.DEF 189876
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nexi-20220630_lab.xml EX-101.LAB 574677
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nexi-20220630_pre.xml EX-101.PRE 361786
68 EXTRACTED XBRL INSTANCE DOCUMENT nexi-20220630_htm.xml XML 857311
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 221166578
SIC: 2834 Pharmaceutical Preparations